NCT03796975View on ClinicalTrials.gov

Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

April 28, 2019

Study Completion Date

November 20, 2019

Conditions
Type 2 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseEfficacy
Interventions
DRUG

Combination of Pioglitazone and Metformin Tablets

15mg/500mg, oral, 2/day

DRUG

Metformin Hydrochloride Tablets

Oral metformin 850mg, 2/day in the control group

Trial Locations (1)

710032

Xijing Hospital, Fourth Military Medical university, Xi'an

All Listed Sponsors
collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

OTHER

collaborator

Shaanxi Aerospace Hospital

UNKNOWN

collaborator

Genertec Universal Xi'an Aero-Engine hospital (Xi' an) Co., Ltd

UNKNOWN

collaborator

Xi'an Gaoxin Hospital

OTHER

collaborator

Chang'An Hospital

OTHER

collaborator

Yan'an people's Hospital

UNKNOWN

collaborator

Shangluo Central Hospital

OTHER

lead

Xijing Hospital

OTHER

NCT03796975 - Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter